Recruiting

Wearable device to improve balance and walking in nerve damage

Plain-English translation of NCT07236515 on ClinicalTrials.gov ↗ · Source last updated July 2026 · Translation generated July 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

This study is testing a non-invasive wearable device called the Leia Sensory Prosthesis to see if it can help people with peripheral neuropathy — a condition that damages nerves in the feet and legs — improve their balance and walking. Half of the participants will wear the active device, while the other half will wear a sham (inactive) version to compare results. Researchers will measure whether the device helps with stability during daily activities and evaluate how safe and comfortable it is to use.

Peripheral neuropathy causes balance and gait problems that can increase fall risk and limit daily activities. This trial aims to find out whether this wearable device could provide a safe, non-invasive way to help people regain stability and confidence in their movement.

Do you qualify?

You likely qualify if…

you are at least 18 years old
you have been clinically diagnosed with peripheral neuropathy confirmed by nerve testing
you experience balance or gait difficulties, confirmed by a balance assessment or inability to stand on one leg for 30 seconds
you are able to walk without walking aids or crutches
you have been on stable medications and supplements for at least one month and can keep them the same during the study
you are willing and able to attend weekly sessions and use the device at home

You likely don't qualify if…

you have untreated wounds, swelling, infections, or skin problems on your feet, ankles, or lower legs
you have an untreated or unhealed fracture in your foot or ankle
you have a pacemaker or other implanted electrical device
you are pregnant or breastfeeding
you have serious blood vessel disease or other orthopedic conditions that severely limit your ability to walk

What participation looks like

If you qualify, you will be randomly assigned to either the active device group or the sham device group. You will wear your assigned wearable device during the study period and attend weekly sessions at the research site. You will also use the device at home as instructed. Researchers will test your balance and walking ability, assess your comfort and safety with the device, and track how well it works for you over the study period.

AI-generated summary from trial data · Jul 16, 2026 · Not medical advice

Trial locations(3 sites)

Switzerland

Hôpital de la Tour, Meyrin

Ensemble Hospitalier de la Côte (EHC), Morges

Universitätsklinik Balgrist, Zurich